BCL2 and B-cell chronic lymphocytic leukemia: Additionally, CLL-specific super-enhancers showed a strong decrease in DNAme compared to normal B samples (Mann–Whitney U-test, P < 0.0001; Fig. 2b, c), as illustrated for the BCL2 gene locus (Fig. 2d).